{"nct_id":"NCT01853878","title":"A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor","status":"COMPLETED","status_verified_date":"2019-08","start_date":"2013-06-12","start_date_type":"ACTUAL","primary_completion_date":"2016-08-24","primary_completion_date_type":"ACTUAL","completion_date":"2016-08-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}